olaparib
merck,astrazeneca
['prostate', 'olaparib']
 a phase 1/2 study of combination olaparib and radium-223 in men with metastatic castration-resistant #prostate cancer with bone metastases (comrade): a trial in progress. at #asco23 
Rutgers Cancer Institute of New Jersey is the state’s only NCI-designated Comprehensive Cancer Center and a leader in patient care and cancer research.